Ruth Olson

3.2k total citations
26 papers, 1.9k citations indexed

About

Ruth Olson is a scholar working on Molecular Medicine, Endocrinology and Epidemiology. According to data from OpenAlex, Ruth Olson has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 14 papers in Endocrinology and 10 papers in Epidemiology. Recurrent topics in Ruth Olson's work include Antibiotic Resistance in Bacteria (24 papers), Escherichia coli research studies (8 papers) and Bacterial Genetics and Biotechnology (6 papers). Ruth Olson is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Escherichia coli research studies (8 papers) and Bacterial Genetics and Biotechnology (6 papers). Ruth Olson collaborates with scholars based in United States, Canada and India. Ruth Olson's co-authors include Thomas A. Russo, Ulrike MacDonald, Janet M. Beanan, Timothy C. Umland, Anthony A. Campagnari, Bruce A. Davidson, Nicole R. Luke, L. Wayne Schultz, Daniel Metzger and Andrew M. Gulick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Ruth Olson

26 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth Olson United States	19	1.5k	909	677	431	258	26	1.9k
Janet M. Beanan United States	19	1.4k 0.9×	895 1.0×	654 1.0×	401 0.9×	236 0.9×	25	1.8k
Ulrike MacDonald United States	20	1.7k 1.1×	1.1k 1.2×	729 1.1×	508 1.2×	290 1.1×	32	2.2k
Yoo Chul Lee South Korea	22	1.4k 0.9×	897 1.0×	744 1.1×	319 0.7×	250 1.0×	43	2.0k
Enrique Llobet Spain	19	1.3k 0.9×	626 0.7×	606 0.9×	366 0.8×	195 0.8×	21	2.1k
Sujay Chattopadhyay United States	23	861 0.6×	1.0k 1.1×	644 1.0×	347 0.8×	212 0.8×	51	2.0k
Sung Yong Seol South Korea	23	1.1k 0.7×	842 0.9×	654 1.0×	236 0.5×	308 1.2×	44	1.8k
Tzu‐Lung Lin Taiwan	27	1.5k 1.0×	685 0.8×	864 1.3×	547 1.3×	351 1.4×	43	2.4k
Qinglan Guo China	23	1.3k 0.8×	476 0.5×	319 0.5×	446 1.0×	215 0.8×	57	1.6k
Tatsuya Tada Japan	24	1.2k 0.8×	551 0.6×	588 0.9×	199 0.5×	189 0.7×	100	1.6k
Izabela Kern-Zdanowicz Poland	15	995 0.7×	458 0.5×	291 0.4×	319 0.7×	153 0.6×	31	1.4k

Countries citing papers authored by Ruth Olson

Since Specialization

Citations

This map shows the geographic impact of Ruth Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Olson more than expected).

Fields of papers citing papers by Ruth Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Olson. The network helps show where Ruth Olson may publish in the future.

Co-authorship network of co-authors of Ruth Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Olson. A scholar is included among the top collaborators of Ruth Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Olson. Ruth Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Russo, Thomas A., Timothy C. Umland, Xiaoyi Deng, et al.. (2022). Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii. Proceedings of the National Academy of Sciences. 119(51). e2213116119–e2213116119. 8 indexed citations

Lin, Shun Xin Wang, Ruth Olson, Janet M. Beanan, et al.. (2019). Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model. Journal of Pharmacology and Experimental Therapeutics. 368(3). 475–489. 17 indexed citations

Russo, Thomas A., et al.. (2016). The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii. mSphere. 1(3). 75 indexed citations

MacDonald, Ulrike, Janet M. Beanan, Ruth Olson, et al.. (2015). Structure of shikimate kinase, anin vivoessential metabolic enzyme in the nosocomial pathogenAcinetobacter baumannii, in complex with shikimate. Acta Crystallographica Section D Biological Crystallography. 71(8). 1736–1744. 7 indexed citations

Russo, Thomas A., Ruth Olson, Ulrike MacDonald, et al.. (2014). Aerobactin Mediates Virulence and Accounts for Increased Siderophore Production under Iron-Limiting Conditions by Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae. Infection and Immunity. 82(6). 2356–2367. 217 indexed citations

Johnson, James R., Thomas A. Russo, Sarah M. Drawz, et al.. (2013). OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis. Microbial Pathogenesis. 64. 1–5. 14 indexed citations

Umland, Timothy C., L. Wayne Schultz, Ulrike MacDonald, et al.. (2012). In Vivo -Validated Essential Genes Identified in Acinetobacter baumannii by Using Human Ascites Overlap Poorly with Essential Genes Detected on Laboratory Media. mBio. 3(4). 70 indexed citations

Kong, Qingli, Janet M. Beanan, Ruth Olson, et al.. (2012). Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model. Virulence. 3(3). 309–318. 17 indexed citations

Russo, Thomas A., et al.. (2011). Hypervirulent K. Pneumoniae Secretes More and More Active Iron-Acquisition Molecules than “Classical” K. Pneumoniae Thereby Enhancing its Virulence. PLoS ONE. 6(10). e26734–e26734. 103 indexed citations

10.

Beanan, Janet M., et al.. (2011). Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. European Journal of Clinical Microbiology & Infectious Diseases. 31(6). 981–989. 174 indexed citations

11.

Russo, Thomas A., Malcolm G. P. Page, Janet M. Beanan, et al.. (2011). In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 66(4). 867–873. 51 indexed citations

12.

Russo, Thomas A., Nicole R. Luke, Janet M. Beanan, et al.. (2010). The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor. Infection and Immunity. 78(9). 3993–4000. 272 indexed citations

13.

Russo, Thomas A., Ulrike MacDonald, Janet M. Beanan, et al.. (2009). Penicillin‐Binding Protein 7/8 Contributes to the Survival ofAcinetobacter baumanniiIn Vitro and In Vivo. The Journal of Infectious Diseases. 199(4). 513–521. 83 indexed citations

14.

Russo, Thomas A., Janet M. Beanan, Ruth Olson, Ulrike MacDonald, & John J. Cope. (2008). Capsular polysaccharide and the O-specific antigen impede antibody binding: A potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine. Vaccine. 27(3). 388–395. 18 indexed citations

15.

Russo, Thomas A., Janet M. Beanan, Ruth Olson, et al.. (2008). Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology. Infection and Immunity. 76(8). 3577–3586. 54 indexed citations

16.

Russo, Thomas A., Zhengdong Wang, Bruce A. Davidson, et al.. (2007). Surfactant dysfunction and lung injury due to theE. colivirulence factor hemolysin in a rat pneumonia model. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(3). L632–L643. 19 indexed citations

17.

Russo, Thomas A., Janet M. Beanan, Ruth Olson, et al.. (2007). A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine. 25(19). 3859–3870. 27 indexed citations

18.

Russo, Thomas A., Bruce A. Davidson, Janet M. Beanan, et al.. (2007). CAPSULE AND O-ANTIGEN FROM AN EXTRAINTESTINAL ISOLATE OFESHERICHIA COLIMODULATE CYTOKINE LEVELS IN RAT MACROPHAGES IN VITRO AND IN A RAT MODEL OF PNEUMONIA. Experimental Lung Research. 33(7). 337–356. 2 indexed citations

19.

Russo, Thomas A., Bruce A. Davidson, Natalie M. Warholic, et al.. (2005). E. colivirulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. American Journal of Physiology-Lung Cellular and Molecular Physiology. 289(2). L207–L216. 66 indexed citations

20.

Russo, Thomas A., et al.. (2003). Human Neutrophil Chemotaxis Is Modulated by Capsule and O Antigen from an Extraintestinal PathogenicEscherichia coliStrain. Infection and Immunity. 71(11). 6435–6445. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact